Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 4 boards, counting each seat separately. Longest: ACADIA Pharmaceuticals Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Madrigal Pharmaceuticals Inc. June 16, 202696.6%
-
Madrigal Pharmaceuticals Inc. June 15, 202360.0%
-
ACADIA Pharmaceuticals Inc. June 1, 202379.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 16, 2026 | Cytokinetics Incorporated | Grant or award | +195 | $63.92 | $12,464 |
| Oct 1, 2026 | Halozyme Therapeutics Inc. | Grant or award | +1,169 | — | — |
| Jul 15, 2026 | Cytokinetics Incorporated | Grant or award | +151 | $82.62 | $12,476 |
| Jun 17, 2026 | Madrigal Pharmaceuticals Inc. | Grant or award | +454 | — | — |
| May 29, 2026 | ACADIA Pharmaceuticals Inc. | Option exercise | +8,107 | — | — |
| May 27, 2026 | Cytokinetics Incorporated | Grant or award | +2,851 | — | — |
| Apr 15, 2026 | Cytokinetics Incorporated | Grant or award | +191 | $65.37 | $12,486 |
| Jan 15, 2026 | Cytokinetics Incorporated | Grant or award | +197 | $63.44 | $12,498 |
| Nov 10, 2025 | ACADIA Pharmaceuticals Inc. | Open-market sale | −30,000 | $22.37 | $671,100 |
| Jun 20, 2025 | Madrigal Pharmaceuticals Inc. | Grant or award | +715 | — | — |
| May 29, 2025 | ACADIA Pharmaceuticals Inc. | Option exercise | +9,387 | — | — |
| Feb 27, 2025 | Madrigal Pharmaceuticals Inc. | Option exercise | +9,470 | $65.06 | $616,118 |
| Feb 27, 2025 | Madrigal Pharmaceuticals Inc. | Option exercise | +6,000 | $111.06 | $666,360 |
| Feb 27, 2025 | Madrigal Pharmaceuticals Inc. | Open-market sale | −398 | $346.90 | $138,066 |
| Feb 27, 2025 | Madrigal Pharmaceuticals Inc. | Open-market sale | −14,302 | $347.39 | $4,968,372 |
Questions about James M. Daly
What boards is James M. Daly on?
James M. Daly sits on the boards of ACADIA Pharmaceuticals Inc., Cytokinetics Incorporated, Halozyme Therapeutics Inc. and Madrigal Pharmaceuticals Inc.
How long has James M. Daly served on boards?
Our records show at least 8 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.